Correlation Between Scpharmaceuticals and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Candel Therapeutics, you can compare the effects of market volatilities on Scpharmaceuticals and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Candel Therapeutics.
Diversification Opportunities for Scpharmaceuticals and Candel Therapeutics
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Scpharmaceuticals and Candel is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Candel Therapeutics
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Candel Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 4.28 times less risky than Candel Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Candel Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 147.00 in Candel Therapeutics on September 1, 2024 and sell it today you would earn a total of 348.00 from holding Candel Therapeutics or generate 236.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Candel Therapeutics
Performance |
| Timeline |
| Scpharmaceuticals |
| Candel Therapeutics |
Scpharmaceuticals and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Candel Therapeutics
The main advantage of trading using opposite Scpharmaceuticals and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |